The following presentation info was posted to the ISIS event calendar today- I will follow up with complete abstracts and/or data as soon as possible:
ISIS PHARMACEUTICALS AT 2011 FASEB SUMMER RESEARCH CONFERENCE
"PROTEASES IN HEMOSTASIS AND VASCULAR BIOLOGY"
JUNE 12-17, 2011
CAREFREE, AZ
Session Type Poster Session
Date Monday & Tuesday, June 13-14, 2011
Time 4:00 p.m. to 6:00 p.m. M.T
Presentation REVERSAL OF VASCULAR PERMEABILITY BY TARGETED
INHIBITION OF PLASMA KALLIKREIN AND FACTOR XII
Gourab Bhattacharjee
Session Type Oral Presentation
Date Tuesday, June 14, 2011
Time 9:10 p.m. – 9:25 p.m. M.T.
Abstract ANTISENSE TECHNOLOGY AS A THERAPEUTIC STRATEGY IN
HAEMOSTATIC AND INFLAMMATION DISORDERS
Alexey Revenko
Session Type Poster Session
Date Wednesday & Thursday, June 15-16, 2011
Time 4:00 p.m. – 6:00 p.m. M.T.
Abstract ANTISENSE-MEDIATED INHIBITION OF COAGULATION
FACTOR XI IS A NOVEL THERAPEUTIC APPROACH TO
RESTRICT INFLAMMATION IN EXPERIMENTAL COLITIS
Alexey Revenko
ISIS PHARMACEUTICALS AT 2011 FASEB SUMMER RESEARCH CONFERENCE
"PROTEASES IN HEMOSTASIS AND VASCULAR BIOLOGY"
JUNE 12-17, 2011
CAREFREE, AZ
Session Type Poster Session
Date Monday & Tuesday, June 13-14, 2011
Time 4:00 p.m. to 6:00 p.m. M.T
Presentation REVERSAL OF VASCULAR PERMEABILITY BY TARGETED
INHIBITION OF PLASMA KALLIKREIN AND FACTOR XII
Gourab Bhattacharjee
Session Type Oral Presentation
Date Tuesday, June 14, 2011
Time 9:10 p.m. – 9:25 p.m. M.T.
Abstract ANTISENSE TECHNOLOGY AS A THERAPEUTIC STRATEGY IN
HAEMOSTATIC AND INFLAMMATION DISORDERS
Alexey Revenko
Session Type Poster Session
Date Wednesday & Thursday, June 15-16, 2011
Time 4:00 p.m. – 6:00 p.m. M.T.
Abstract ANTISENSE-MEDIATED INHIBITION OF COAGULATION
FACTOR XI IS A NOVEL THERAPEUTIC APPROACH TO
RESTRICT INFLAMMATION IN EXPERIMENTAL COLITIS
Alexey Revenko
RSS Feed
